19 stories found
Orthopedic technology firm Globus Medical has finalized the acquisition of Higgs Boson Health to integrate artificial intelligence tools into its clinical offerings. The deal aims to enhance patient outcomes through advanced digital health solutions.
The Madison Small Cap Fund has sold its shares in Globus Medical due to valuation concerns and divested from Chord Energy Corporation to pursue more compelling investment opportunities.
Wells Fargo has lowered its price target for Globus Medical (GMED), despite the company reporting strong first-quarter sales and earnings per share that exceeded expectations.
A range of companies, including Haverty Furniture, Health Catalyst, and Herbalife, have released or previewed their first-quarter financial results. These reports highlight key performance indicators and financial outcomes for the recent quarter.
Globus Medical (GMED) published its earnings transcript for the first quarter of 2026.
Globus Medical (GMED) shares have declined following challenges related to its recent acquisition and performance in its robotics segment.
This cluster includes news on analyst ratings, significant investment filings, regulatory compliance, proposed rights issues, and new business orders for individual companies.
Globus Medical's second-quarter earnings call provided an overview of its financial performance and key developments in the medical technology sector.
Globus Medical (GMED) is identified as one of the most profitable growth stocks available for investors.
Financial analyst Jim Cramer expressed a cautious view on Globus Medical, suggesting limited profit potential in the stock.
Several companies across various sectors have released their financial forecasts and guidance for 2026. These projections detail expected revenues, adjusted EBITDA, and other key performance metrics for the upcoming fiscal year.
Bares Capital has reportedly purchased shares in Globus Medical Inc. (GMED), indicating a new investment in the medical technology company.
Globus Medical, Inc. held its Q4 2025 earnings call, providing a summary of its financial results for the quarter.
Several companies, including Recruit Holdings, Daimler Truck, Arteris, and ICU Medical, have updated or raised their financial outlooks for fiscal year 2026. These revisions reflect various factors such as strong performance, strategic initiatives, and market conditions.
Globus Medical, Inc. (GMED) is identified as a cheap robotics stock demonstrating strong performance. The company is reportedly firing on all cylinders with significant earnings and revenue growth.
Several financial firms have lowered their price targets for companies including Exelon, AbbVie, and Shell. Some of these reductions occurred despite the companies reporting strong quarterly earnings.
Globus Medical has set its 2026 non-GAAP EPS target at $4.70-$4.80 and reaffirmed its revenue guidance of $3.18B-$3.22B. Separately, ACM Research reiterated its 2026 revenue outlook of $1.08B-$1.175B and aims for 15-20 single-wafer SPM tool deliveries by year-end.
Wells Fargo has begun its coverage of Globus Medical (GMED), assigning an "Overweight" rating to the medical device company's stock.
Globus Medical has increased its earnings per share guidance for 2026 to $4.40-$4.50, citing margin gains following record-breaking fourth-quarter results.